BIB icon

ProShares Ultra NASDAQ Biotechnology
BIB

Overview Fund Activity

26 hedge funds and large institutions have $7.07M invested in ProShares Ultra NASDAQ Biotechnology in 2020 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
–
Holders Change %
0%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
7
Closed
6
Calls
$4M
Puts
$2.23M
Net Calls
+$1.77M
Net Calls Change
+$679K

Top Buyers

1
TFA
1
Toth Financial Advisory
Virginia
$852K
2
TI
2
Trexquant Investment
Connecticut
$261K
3
Simplex Trading
3
Simplex Trading
Illinois
$238K
4
Morgan Stanley
4
Morgan Stanley
New York
$200K
5
Bank of America
5
Bank of America
North Carolina
$79K

Top Sellers

1
GWM
1
Geneos Wealth Management
Colorado
$7K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$353K
3
BG
3
Bellevue Group
Switzerland
$0
4
Jane Street
4
Jane Street
New York
$0
5
TRCT
5
Tower Research Capital (TRC)
New York
$41K
Name Holding Trade Value Shares
Change 		Shares
Change %
GWM
26
Geneos Wealth Management
Colorado
$7K -$3.87M -101,270 -100%
BG
27
Bellevue Group
Switzerland
– -$1.54M -25,000 Closed
Jane Street
28
Jane Street
New York
– -$1.5M -24,327 Closed
LPL Financial
29
LPL Financial
California
– -$226K -3,660 Closed
CG
30
Cutler Group
California
– -$57K -926 Closed
BNP Paribas Financial Markets
31
BNP Paribas Financial Markets
France
– -$10.3K -167 Closed
IA
32
IFP Advisors
Florida
– -$8K -120 Closed
1
2